SALT LAKE CITY — BioFire Diagnostics, Inc., recently announced that it has commenced clinical and analytical studies to evaluate the company’s FilmArray Gastrointestinal (GI) Panel, with plans to seek both CE IVD marking and FDA clearance. The comprehensive 23-target panel tests for common bacteria, viruses and protozoa that cause infectious diarrhea. The test is performed […]
FREMONT, Calif.–Clinical laboratory staff now have a tool that combines routine and cardiac/STAT monitoring markers for patients without the need for separate QC. The Thermo Scientific MAS Omni•CARDIO controls consolidate routine cardiac markers including Troponin I and T, CK-MB, Myoglobin, NT-proBNP and BNP-32 with several new cardiac/STAT markers including Myeloperoxidase, hCG, D-Dimer and Procalcitonin. These […]
Northfield, IL and Franklin Lakes, NJ – BD Diagnostics, a segment of BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, and the College of American Pathologists (CAP), the world leader in laboratory quality assurance and improvement, today announced the launch of a new strategic alliance that will provide solutions to […]
HOUSTON — Roche (SIX: RO, ROG; OTCQX: RHHBY) announced plans today at the AACC 2013 Clinical Lab Expo for the U.S. introduction of the cobas 8100 automated workflow series, an advanced system designed to automate many routine tasks to help diagnostic laboratories increase efficiency, reduce expenses and maximize patient safety. “This total lab automation solution […]
Washington, DC — SISCAPA Assay Technologies, Inc. (SAT) announced publication of a study in Clinical Chemistry demonstrating that a SISCAPA-MALDI-TOF assay for protein C inhibitor can help identify patients at risk for recurrence of prostate cancer after radiotherapy. The assay measures a proteotypic peptide of protein C inhibitor enriched from tryptic digests of patient serum […]
HENNIGSDORF, Germany – Thermo Fisher Scientific Inc., the world leader in serving science, today announced the renewal of its non-exclusive, long-term, royalty-bearing agreement with Roche for the use of Thermo Fisher’s Procalcitonin (B.R.A.H.M.S PCTTM) technology, currently available as an automated immunoassay on the Roche Elecsys® cobas e platforms in all countries outside the United States. […]
HATFIELD, Pa — Genisphere LLC has licensed its 3DNA® Signal Amplification technology to Chembio Diagnostics, Inc., a leader in point-of-care (“POC”) diagnostic tests for infectious diseases. Chembio plans to use the signal enhancing technology for its Dual Path Platform (“DPP®”) rapid diagnostic pipeline tests, with the goal of achieving detection limits unique to rapid immunoassays […]
Danvers, MA – Cell Signaling Technology, Inc. (CST) of Danvers, MA, announced today that it has granted Cepheid, Inc., a worldwide non-exclusive license to CST patent rights relating to the detection of ALK gene rearrangements for the field of PCR (polymerase chain reaction) diagnostic testing. Cepheid will develop a test, which is intended to identify […]
SEATTLE and HOUSTON – NanoString Technologies, Inc. (NASDAQ: NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced an Early Access Program for nCounter Elements™, a line of General Purpose Reagents (GPRs) developed specifically to meet the needs of translational research and clinical laboratories. nCounter Elements GPRs enable researchers […]
LEXINGTON, Mass. — Quanterix Corporation, a leader in high definition diagnostics, delivering ultrasensitive single molecule measurement for the benefit of human health, today announced that they will be attending the AACC Annual Meeting and Clinical Lab Expo on July 28 – August 1, 2013 in Houston, Texas. Quanterix will be presenting research based on its […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
